Friday 6 November 2026
Export TCMD’s income statement to Excel — free account
Tactile Systems Technology, Inc.
TCMD Healthcare Medical Devices
Tactile Systems Technology, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $329.5 million, up 12.5% from fiscal 2024.
- Revenue
- +7.12%
- EPS
- −14.5%
- Free cash flow
- +23.8%
Quarter to September 2026, against a year earlier
26.07
0.30
−1.14%
Follow TCMD
Alert me
| Older periods | Dec '25 | Mar '26 | Jun '26 | Sep '26 | |
|---|---|---|---|---|---|
Piotroski F-Score |
+8 more TTM periods Free account |
8 | 8 | 9 | 8 |
| 8.77% | 9.59% | 11.88% | 11.02% | ||
| 6.67% | 7.35% | 9.00% | 8.65% | ||
ROIC |
15.29% | 15.81% | 15.74% | 15.33% | |
Return on Tangible Assets |
14.76% | 16.63% | 19.86% | 19.06% | |
Average Days of Receivables |
48.60 | 40.61 | 45.90 | 50.02 | |
Free Cash Flow per Share |
1.76 | 1.73 | 1.18 | 1.28 | |
Free Cash Flow |
40.28 | 39.09 | 26.67 | 28.86 | |
Capital Expenditures |
(2.53) | (2.96) | (3.88) | (3.33) | |
| Other line items | |||||
Cash ROIC |
12.66% | 12.69% | 8.64% | 9.10% | |
Accounts Receivable Turnover |
7.42 | 9.15 | 9.03 | 8.28 | |
Accounts Payable Turnover |
14.95 | 11.31 | 10.20 | 8.29 | |
Inventory Turnover |
4.86 | 4.58 | 4.79 | 5.17 | |
Average Days of Payables |
22.84 | 32.06 | 35.55 | 52.52 | |
Days of Inventory on Hand |
64.49 | 74.62 | 75.59 | 69.46 | |
Tax Rate |
(0.39) | (0.41) | (0.33) | (0.34) | |
Research and Development Expense of Revenue |
2.57% | 2.77% | 2.85% | 2.89% | |
Selling, General and Administrative Expense of Revenue |
63.71% | 63.52% | 63.23% | 63.96% | |
Share Based Compensation of Revenue |
2.54% | 2.35% | 2.40% | 2.51% | |
Interest Coverage |
28.21 | 50.29 | 139.56 | 431.51 | |
Operating CF/Net income |
2.24 | 2.07 | 1.23 | 1.35 | |
Depreciation/Fixed assets |
1.30 | 1.26 | 1.15 | 1.20 | |
Capex/Depreciation |
(0.38) | (0.45) | (0.58) | (0.49) | |
Revenue per Share |
14.41 | 15.23 | 15.45 | 15.75 | |
Operating CF per Share |
1.87 | 1.86 | 1.35 | 1.42 | |
Capex per Share |
(0.11) | (0.13) | (0.17) | (0.15) | |
Capex to Sales |
0.01 | 0.01 | 0.01 | 0.01 |
Columns are period end dates · fundamentals updated 5 Nov 2026